Steven Dubinett, MD, is associate vice chancellor for research and director of the lung cancer research program at UCLA’s Jonsson Comprehensive Cancer Center. He is chief of the division of pulmonary and critical care medicine and jointly appointed as professor in the Departments of Medicine, Pathology and Laboratory Medicine, and Molecular and Medical Pharmacology.
Dr. Dubinett conducts translational research in the immunobiology of lung cancer. Building on original discoveries regarding inflammation in human non-small cell lung cancer (NSCLC), he has developed a translational research program, which now utilizes these laboratory-based studies in the laboratory and clinical setting. His laboratory has identified inflammation-dependent genes and proteins mediating angiogenesis, apoptosis resistance, invasion and immune suppression in NSCLC. His studies focus on the microenvironment, inflammation and epithelial mesenchymal transition in the pathogenesis of lung cancer.
He has served as a member of the U.S. Food and Drug Administration Cellular, Tissue and Gene Therapies Advisory Committee and on several editorial boards including Clinical and Translational Science, and he is an associate editor-in-chief of the American Journal of Translational Research.